INTUITIVE SURGICAL INC
ISRGNASDAQ🏆 #90 by market capEarnings Jan 20 · PostUS Equity
$444.18▼ $1.69 (−0.38%)
After hours · at closeTrack ISRG
Get earnings, price moves & breaking news on Telegram
24h▼ 0.4%
7d▲ 3.7%
14d▲ 5.7%
30d▲ 7.1%
ytd▼ 21.6%
1y▼ 18.6%
🏦Market Cap
$153.97B
Mid Cap
📈Revenue Growth (YoY)
20.4%
Healthy
📊Gross Margin
67.2%
High
💵FCF Margin
31.1%
Strong
⚖️P/S Ratio
13.6x
Elevated
Otter Score
80
Strong
INTUITIVE SURGICAL INC
ISRGAnalyst Ratings
Price
$444.18
Total
57
Raised
14
Lowered
8
Avg PT
$485.44
H / L
$558 / $357
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
RBC Capital | Reiterated | Outperform | 2026-10-21 | $550.00 | +23.80% |
Mizuho | Reiterated | Neutral | 2026-10-21 | — | — |
Baird | Reiterated | Outperform | 2026-10-21 | — | — |
BTIG | Reiterated | Buy | 2026-10-21 | $454.00 | +2.20% |
Evercore ISI Group | Reiterated | In Line | 2026-10-21 | — | — |
Wells Fargo | Reiterated | Overweight | 2026-10-21 | $486.00 | +9.40% |
TD Cowen | Reiterated | Buy | 2026-10-21 | — | — |
Barclays | Reiterated | Overweight | 2026-10-21 | $500.00 | +12.60% |
Leerink Partners | Reiterated | Outperform | 2026-10-21 | $503.00 | +13.20% |
JP Morgan | Reiterated | Overweight | 2026-10-21 | $280.00 | −37.00% |
Oppenheimer | Upgraded | Perform → Outperform | 2026-08-12 | $500.00 | +12.60% |
HSBC | Downgraded | Buy → Hold | 2026-07-30 | $391.00 | −12.00% |
Citigroup | Reiterated | Buy | 2026-07-17 | $560.00 | +26.10% |
Stifel | Reiterated | Buy | 2026-07-17 | — | — |
Bernstein | Reiterated | Outperform | 2026-07-17 | $750.00 | +68.90% |
Raymond James | Reiterated | Outperform | 2026-07-17 | $480.00 | +8.10% |
Piper Sandler | Reiterated | Overweight | 2026-07-17 | $357.44 | −19.50% |
Truist Securities | Reiterated | Buy | 2026-07-16 | — | — |
B of A Securities | Reiterated | Buy | 2026-05-18 | — | — |
Goldman Sachs | Reiterated | Buy | 2026-04-09 | $558.00 | +25.60% |
UBS | Reiterated | Neutral | 2026-03-17 | $500.00 | +12.60% |
Freedom Capital Markets | Upgraded | Hold → Buy | 2026-01-27 | — | — |
Freedom Broker | Upgraded | Hold → Buy | 2026-01-26 | — | — |
Deutsche Bank | Downgraded | Hold → Sell | 2025-06-09 | $390.00 | −12.20% |
Morgan Stanley | Upgraded | Equal Weight → Overweight | 2024-12-02 | $650.00 | +46.30% |
Erste Group | Upgraded | Hold → Buy | 2024-11-19 | — | — |
Redburn Atlantic | Upgraded | Neutral → Buy | 2024-08-02 | — | — |
Jefferies | Reiterated | Hold | 2024-04-19 | $375.00 | −15.60% |
William Blair | Reiterated | Outperform | 2023-03-23 | — | — |
Argus Research | Reiterated | Buy | 2022-12-22 | $320.00 | −28.00% |
Wolfe Research | Reiterated | Peer Perform → Perform | 2022-04-06 | — | — |
Redburn Partners | Downgraded | Buy → Neutral | 2022-01-25 | — | — |
SVB Leerink | Reiterated | Market Perform | 2021-08-26 | — | — |
Canaccord Genuity | Reiterated | Buy | 2020-07-22 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2020-01-10 | — | — |
First Shanghai | Reiterated | Buy | 2019-11-29 | — | — |
PiperJaffray | Upgraded | Neutral → Overweight | 2018-10-10 | — | — |
Stifel Nicolaus | Reiterated | Buy | 2018-07-20 | $550.00 | +23.80% |
Bank of America | Reiterated | Buy | 2018-07-17 | — | — |
BTIG Research | Downgraded | Buy → Neutral | 2016-04-01 | — | — |
Northland Securities | Upgraded | Underperform → Market Perform | 2014-10-22 | — | — |
Northland Capital Markets | Upgraded | Underperform → Market Perform | 2014-10-22 | — | — |
Leerink Swann | Upgraded | Market Perform → Outperform | 2014-10-17 | — | — |
Sterne Agee | Upgraded | Underperform → Neutral | 2014-04-29 | — | — |
SunTrust Robinson Humphrey | Reiterated | Buy | 2014-04-23 | — | — |
JMP Securities | Upgraded | Market Underperform → Market Outperform | 2014-04-02 | — | — |
ISI Group | Downgraded | Strong Buy → Buy | 2014-01-21 | — | — |
CRT Capital | Reiterated | Sell | 2013-11-26 | — | — |
Northland | Downgraded | Market Perform → Underperform | 2013-10-18 | — | — |
First Analysis | Downgraded | Equal Weight → Underweight | 2013-09-03 | — | — |
Ameriprise Financial | Downgraded | Buy → Sell | 2013-07-09 | — | — |
Wedbush | Reiterated | Outperform | 2013-06-18 | — | — |
Janney Capital | Reiterated | Buy | 2013-01-18 | — | — |
Lazard | Upgraded | Neutral → Buy | 2013-01-14 | — | — |
Barrington Research | Upgraded | Market Perform → Outperform | 2012-10-31 | — | — |
Dougherty & Co. | Reiterated | Buy | 2012-04-18 | — | — |
Dougherty | Reiterated | Buy | 2012-04-18 | — | — |
Institution
RBC Capital
Reiterated · Outperform · 2026-10-21
$550.00
+23.80%
Mizuho
Reiterated · Neutral · 2026-10-21
—
—
Baird
Reiterated · Outperform · 2026-10-21
—
—
BTIG
Reiterated · Buy · 2026-10-21
$454.00
+2.20%
Evercore ISI Group
Reiterated · In Line · 2026-10-21
—
—
Wells Fargo
Reiterated · Overweight · 2026-10-21
$486.00
+9.40%
TD Cowen
Reiterated · Buy · 2026-10-21
—
—
Barclays
Reiterated · Overweight · 2026-10-21
$500.00
+12.60%
Leerink Partners
Reiterated · Outperform · 2026-10-21
$503.00
+13.20%
JP Morgan
Reiterated · Overweight · 2026-10-21
$280.00
−37.00%
Oppenheimer
Upgraded · Perform → Outperform · 2026-08-12
$500.00
+12.60%
HSBC
Downgraded · Buy → Hold · 2026-07-30
$391.00
−12.00%
Citigroup
Reiterated · Buy · 2026-07-17
$560.00
+26.10%
Stifel
Reiterated · Buy · 2026-07-17
—
—
Bernstein
Reiterated · Outperform · 2026-07-17
$750.00
+68.90%
Raymond James
Reiterated · Outperform · 2026-07-17
$480.00
+8.10%
Piper Sandler
Reiterated · Overweight · 2026-07-17
$357.44
−19.50%
Truist Securities
Reiterated · Buy · 2026-07-16
—
—
B of A Securities
Reiterated · Buy · 2026-05-18
—
—
Goldman Sachs
Reiterated · Buy · 2026-04-09
$558.00
+25.60%
UBS
Reiterated · Neutral · 2026-03-17
$500.00
+12.60%
Freedom Capital Markets
Upgraded · Hold → Buy · 2026-01-27
—
—
Freedom Broker
Upgraded · Hold → Buy · 2026-01-26
—
—
Deutsche Bank
Downgraded · Hold → Sell · 2025-06-09
$390.00
−12.20%
Morgan Stanley
Upgraded · Equal Weight → Overweight · 2024-12-02
$650.00
+46.30%
Erste Group
Upgraded · Hold → Buy · 2024-11-19
—
—
Redburn Atlantic
Upgraded · Neutral → Buy · 2024-08-02
—
—
Jefferies
Reiterated · Hold · 2024-04-19
$375.00
−15.60%
William Blair
Reiterated · Outperform · 2023-03-23
—
—
Argus Research
Reiterated · Buy · 2022-12-22
$320.00
−28.00%
Wolfe Research
Reiterated · Peer Perform → Perform · 2022-04-06
—
—
Redburn Partners
Downgraded · Buy → Neutral · 2022-01-25
—
—
SVB Leerink
Reiterated · Market Perform · 2021-08-26
—
—
Canaccord Genuity
Reiterated · Buy · 2020-07-22
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2020-01-10
—
—
First Shanghai
Reiterated · Buy · 2019-11-29
—
—
PiperJaffray
Upgraded · Neutral → Overweight · 2018-10-10
—
—
Stifel Nicolaus
Reiterated · Buy · 2018-07-20
$550.00
+23.80%
Bank of America
Reiterated · Buy · 2018-07-17
—
—
BTIG Research
Downgraded · Buy → Neutral · 2016-04-01
—
—
Northland Securities
Upgraded · Underperform → Market Perform · 2014-10-22
—
—
Northland Capital Markets
Upgraded · Underperform → Market Perform · 2014-10-22
—
—
Leerink Swann
Upgraded · Market Perform → Outperform · 2014-10-17
—
—
Sterne Agee
Upgraded · Underperform → Neutral · 2014-04-29
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2014-04-23
—
—
JMP Securities
Upgraded · Market Underperform → Market Outperform · 2014-04-02
—
—
ISI Group
Downgraded · Strong Buy → Buy · 2014-01-21
—
—
CRT Capital
Reiterated · Sell · 2013-11-26
—
—
Northland
Downgraded · Market Perform → Underperform · 2013-10-18
—
—
First Analysis
Downgraded · Equal Weight → Underweight · 2013-09-03
—
—
Ameriprise Financial
Downgraded · Buy → Sell · 2013-07-09
—
—
Wedbush
Reiterated · Outperform · 2013-06-18
—
—
Janney Capital
Reiterated · Buy · 2013-01-18
—
—
Lazard
Upgraded · Neutral → Buy · 2013-01-14
—
—
Barrington Research
Upgraded · Market Perform → Outperform · 2012-10-31
—
—
Dougherty & Co.
Reiterated · Buy · 2012-04-18
—
—
Dougherty
Reiterated · Buy · 2012-04-18
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space